Clover Health Investments Corp
NASDAQ:CLOV

Watchlist Manager
Clover Health Investments Corp Logo
Clover Health Investments Corp
NASDAQ:CLOV
Watchlist
Price: 3.28 USD 2.5% Market Closed
Market Cap: $1.7B

Wall St Price Targets

CLOV Price Targets Summary
Clover Health Investments Corp

Wall Street analysts forecast CLOV stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLOV is 2.6 USD with a low forecast of 1.77 USD and a high forecast of 3.36 USD.

Lowest Forecast
Price Target
1.77 USD
46% Downside
Average Forecast
Price Target
2.6 USD
21% Downside
Highest Forecast
Price Target
3.36 USD
2% Upside
Clover Health Investments Corp Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 5 years is 21%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CLOV's stock price target?
Price Target
2.6 USD

According to Wall Street analysts, the average 1-year price target for CLOV is 2.6 USD with a low forecast of 1.77 USD and a high forecast of 3.36 USD.

What is the Revenue forecast for Clover Health Investments Corp?
Projected CAGR
21%

The compound annual growth rate for Revenue over the next 5 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett